| Wātea: | |
|---|---|
| Rahi: | |
Ko te kōpaki tauira whanui - Ka kapi i te IgE-ti'aturi (OVA), te kaiwhakahohe o te pūtau mast tika (C48/80), me nga tikanga whakamaarama hāngū (PCA).
He maha nga momo / riaka - BALB / c, C57BL / 6 kiore me nga kiore Wistar e waatea ana.
Nga pito matawhānui – Te taumaha o te tinana, te tatau eosinophil, te IgE serum, te whakahekenga o te mast cell, te pupuhi o te waewae, te tangohanga kahurangi Evans, te histopathology (HE, toluidine blue).
Te uara whakamaoritanga - He pai mo te whakamatautau i nga koiora anti-IgE, te whakapumau pūtau mast, H1-antihistamines, me te MRGPRX2 antagonists.
Nga kohinga raraunga kua rite IND - Ka taea te whakahaere rangahau i runga i nga tikanga o te GLP.
OVA Induced BALB/c Tauira Urticaria

OVA Induced C57BL/6 Tauira Urticaria

C48/80 Te Whakatairanga BALB/c Acute Urticaria Model

DNP-IgE & DNFB Whakaawehia te tauira BALB/c PCA

Tauira PCA kiore OVA

• Te whakamatautau kaha o nga immunomodulators (corticosteroids, mycophenolate, cyclophosphamide) mo te IgAN
• Aromatawai i nga apiha renoprotective me te angiotensin-converting enzyme (ACE) aukati
• Te whakamanatanga whainga mo te IgA parepare matatini waipara me te whakahohenga o te mesangial cell
• Te kitenga tohu koiora (albuminuria, serum IgA taumata)
• Maatauranga rongoora me te paitini whakaahei IND
Tauira |
Momo/Riki |
Tikanga Whakauru | Nga Whakamutunga Matua | Te Roanga Ako |
OVA Induced BALB/c Tauira Urticaria |
BALB/c kiore |
OVA + sensitization alum + wero OVA intradermal | Te taumaha o te tinana, te eosinophils, te serum IgE, te whakahekenga o te mast cell, te tohu HE | 4–6 wiki |
OVA Induced C57BL/6 Tauira Urticaria |
C57BL/6 kiore | OVA + sensitization alum + wero OVA intradermal | Te whakahekenga o te pūtau mast, IgE serum, eosinophils | 4–6 wiki |
C48/80 Te Whakatairanga BALB/c Acute Urticaria Model |
BALB/c kiore | Intradermal C48/80 | Te pupuhi o te waewae, Evans kahurangi extravasation | 30 min – 24 haora |
DNP-IgE & DNFB Whakaawehia te tauira BALB/c PCA |
BALB/c kiore |
Intradermal DNP-IgE + DNFB kaupapa | Te tau urticaria, nga mamae mamae | 24–48h |
| Tauira PCA kiore OVA | Kiore Wistar | Intradermal OVA-sensitized serum + iv OVA me Evans puru | Te matotoru o te taringa, Evans kikorangi OD, te whakahekenga o te pūtau mast | 24–48h |
A1: Ka tukuna e matou e rua nga tauira primate kore-tangata (NHP): tauira urticaria i whakaawehia e HDM me te tauira DNP-IgE & DNFB-induced passive cutaneous cutaneous anaphylaxis (PCA).
A2: Ka mahi te HDM hei mate pawera ki te whakaohooho me te wero, ka puta nga tauhohenga kiri o te kiri me te mura me te whakahekenga o te mast cell. Ko te tauira PCA ka whakapouri i te momo I hypersensitivity ma te IgE-mediated allergic responses.
A3: Ka kite matou i te urticaria haumanu me nga tohu PCA. Ka whakamatauhia e matou nga eosinophils me nga pūtau mast, ka kitea te IgE serum, ka whakahaere i te tae kikorangi HE me te toluidine mo te tātari pathological.
A4: Kei roto i te tauira HDM nga wahanga whakamohiotanga me te wero, e 28 nga ra katoa. Ko te tauira PCA ka whakaoti i te werohanga IgE i te Ra 0 me te whakaihiihi DNFB i te Ra 1 mo te tirohanga urupare tonu.